Company
Interpace Biosciences
Bringing Insights to Life
Also known as Interpace Biosciences, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Customers
- healthcare providers
- Legal name
- Interpace Biosciences, Inc.
- interpace.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Interpace Biosciences® (IDXGD) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer.
Funding snapshot
- Total raised
- $113MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $47M2024-10-11
Funding rounds
- Round, 2024
- $47M2024-10-11, SEC form D sold, 2 investors
- Round, 2020
- $47M2020-01-10, SEC form D sold, 2 investors
- Round, 2019
- $14M2019-07-15, SEC form D sold, 1 investor
- Round, 2017
- $5M2017-10-12, SEC form D sold, 4 investors
- Round, 2017
- $111K2017-01-20, SEC form D sold, 6 investors
Products
- Other
- ThyGeNEXT
- Other
- ThyraMIRv2
Loading relationship preview